Candriam Equities L Biotech.R USD Acc/ LU0942225912 /
| NAV10/9/2024 | Chg.-0.6100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 293.0100USD | -0.21% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | - | - | - | - | - | - | - | - | - | 1.68 | - |
| 2014 | 8.32 | 7.40 | -9.88 | -5.03 | 2.83 | 10.18 | -3.18 | 11.14 | -1.05 | 9.67 | 3.04 | 0.65 | +36.60% |
| 2015 | 4.53 | 4.60 | 1.93 | -5.05 | 10.81 | 0.70 | 4.23 | -10.89 | -11.33 | 7.88 | 3.49 | 0.39 | +9.00% |
| 2016 | -23.19 | -4.52 | 3.75 | 3.75 | 5.66 | -8.35 | 12.63 | -2.32 | 4.04 | -12.67 | 9.19 | -2.77 | -18.88% |
| 2017 | 5.58 | 6.90 | 0.16 | 1.14 | -2.88 | 9.44 | 2.46 | 6.89 | 0.96 | -6.54 | 0.19 | 1.52 | +27.71% |
| 2018 | 6.76 | -4.56 | -2.08 | -3.16 | 4.67 | 0.87 | 4.47 | 4.19 | -2.05 | -13.96 | 4.19 | -8.27 | -10.56% |
| 2019 | 13.20 | 3.62 | -0.50 | -4.89 | -4.42 | 9.49 | -2.14 | -2.31 | -4.46 | 11.26 | 12.03 | 2.85 | +36.03% |
| 2020 | -5.22 | -1.47 | -4.93 | 12.42 | 9.55 | 1.34 | -2.95 | 0.90 | 0.77 | -2.60 | 9.52 | 3.04 | +20.18% |
| 2021 | 1.87 | -2.55 | -4.22 | 2.77 | -2.21 | 6.41 | -1.41 | 3.95 | -4.19 | 0.21 | -4.33 | 2.46 | -1.91% |
| 2022 | -10.53 | -1.50 | 6.10 | -7.18 | -3.92 | 3.56 | 4.77 | 1.59 | -1.85 | 6.56 | 6.24 | -2.81 | -0.72% |
| 2023 | 2.98 | -5.61 | 0.31 | 2.33 | -0.88 | 1.49 | -0.51 | -0.16 | -4.43 | -6.06 | 6.23 | 13.70 | +8.10% |
| 2024 | 1.56 | 1.41 | 0.03 | -6.18 | 3.89 | 5.71 | 6.42 | 1.81 | -2.35 | -0.33 | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.18% | 16.44% | 17.53% | 20.17% | 22.57% |
| Sharpe ratio | 0.77 | 1.25 | 1.33 | 0.16 | 0.43 |
| Best month | +13.70% | +6.42% | +13.70% | +13.70% | +13.70% |
| Worst month | -6.18% | -6.18% | -6.18% | -10.53% | -10.53% |
| Maximum loss | -10.94% | -7.07% | -10.94% | -27.07% | -29.90% |
| Outperformance | -3.63% | - | -4.64% | +3.57% | +0.83% |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,232.6299 | +23.02% | +8.87% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,392.1201 | +20.86% | +23.76% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,604.0300 | +17.21% | +21.12% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,023.5200 | +26.95% | +21.30% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 237.7900 | +20.84% | +23.93% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 380.4800 | +18.29% | +25.49% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 352.1100 | +21.98% | +27.27% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 216.7700 | +21.04% | +6.97% | |
| Candriam Equities L Biotechnolog... | reinvestment | 161.8500 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 654.1500 | +25.06% | +16.00% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,142.6299 | +25.44% | +17.01% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,246.3701 | +25.58% | +17.43% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 214.1400 | +23.11% | +9.18% | |
| Candriam Equities L Biotech.R US... | reinvestment | 293.0100 | +26.63% | +20.39% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 224.0200 | +24.15% | +11.89% | |
| Candriam Equities L Biotechnolog... | reinvestment | 919.5200 | +25.52% | +17.41% | |
| Candriam Equities L Biotechnolog... | paying dividend | 839.6800 | +25.48% | +17.30% |
Performance
| YTD | +11.91% | ||
|---|---|---|---|
| 6 Months | +11.28% | ||
| 1 Year | +26.63% | ||
| 3 Years | +20.39% | ||
| 5 Years | +84.68% | ||
| 10 Years | +126.54% | ||
| Since start | +193.01% | ||
| Year | |||
| 2023 | +8.10% | ||
| 2022 | -0.72% | ||
| 2021 | -1.91% | ||
| 2020 | +20.18% | ||
| 2019 | +36.03% | ||
| 2018 | -10.56% | ||
| 2017 | +27.71% | ||
| 2016 | -18.88% | ||
| 2015 | +9.00% | ||
